Miravo Healthcare™ Announces Second Quarter 2022 Results Release Date and Conference Call Details
Nuvo Pharmaceuticals Inc. (MRVFF) d/b/a Miravo Healthcare will release its Q2 2022 financial results before the market opens on August 15, 2022. Following the release, a conference call is scheduled for 11:00 a.m. ET on the same day, hosted by President & CEO Jesse Ledger along with senior management. Investors can participate via dial-in or access the audio webcast online. The company focuses on acquiring growth-oriented healthcare products in various therapeutic areas including pain and neurology.
- Scheduled Q2 2022 financial results release indicates transparency.
- Conference call provides an opportunity for investor engagement.
- None.
The Company will subsequently hold a conference call the same day,
CONFERENCE CALL DETAILS
DATE:
TIME:
DIAL-IN NUMBERS: 416 764 8646 or 1 888 396 8049
The audio webcast and webcast replay can be accessed at:
https://app.webinar.net/5vYkXrPwmEa
About
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005122/en/
Investor Relations
905 673-6980 / option 2
ir@miravohealth.com
Source:
FAQ
When will Miravo Healthcare release its Q2 2022 financial results?
What time is the conference call for Miravo Healthcare's Q2 results?
How can I access the Q2 financial results conference call for MRVFF?